Update -- abeona therapeutics® and lurie children's open first center for zevaskyn™ gene therapy to treat wounds in painful skin disorder

- zevaskyn, the first and only cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (rdeb), now commercially available in the u.s. -

ABEO Ratings Summary

ABEO Quant Ranking